Patel Sangita B, Cameron Patricia M, O'Keefe Stephen J, Frantz-Wattley Betsy, Thompson Jed, O'Neill Edward A, Tennis Trevor, Liu Luping, Becker Joseph W, Scapin Giovanna
Department of Global Structural Biology, Merck Research Laboratory, Rahway, NJ 07065, USA.
Acta Crystallogr D Biol Crystallogr. 2009 Aug;65(Pt 8):777-85. doi: 10.1107/S090744490901600X. Epub 2009 Jul 10.
The p38 mitogen-activated protein kinases are activated in response to environmental stress and cytokines and play a significant role in transcriptional regulation and inflammatory responses. Of the four p38 isoforms known to date, two (p38alpha and p38beta) have been identified as targets for cytokine-suppressive anti-inflammatory drugs. Recently, it was reported that specific inhibition of the p38alpha isoform is necessary and sufficient for anti-inflammatory efficacy in vivo, while further inhibition of p38beta may not provide any additional benefit. In order to aid the development of p38alpha-selective compounds, the three-dimensional structure of p38beta was determined. To do so, the C162S and C119S,C162S mutants of human MAP kinase p38beta were cloned, expressed in Escherichia coli and purified. Initial screening hits in crystallization trials in the presence of an inhibitor led upon optimization to crystals that diffracted to 2.05 A resolution and allowed structure determination (PDB codes 3gc8 and 3gc9 for the single and double mutant, respectively). The structure of the p38alpha C162S mutant in complex with the same inhibitor is also reported (PDB code 3gc7). A comparison between the structures of the two kinases showed that they are highly similar overall but that there are differences in the relative orientation of the N- and C-terminal domains that causes a reduction in the size of the ATP-binding pocket in p38beta. This difference in size between the two pockets could be exploited in order to achieve selectivity.
p38丝裂原活化蛋白激酶可响应环境应激和细胞因子而被激活,并在转录调控和炎症反应中发挥重要作用。在迄今已知的四种p38亚型中,有两种(p38α和p38β)已被确定为细胞因子抑制性抗炎药物的作用靶点。最近有报道称,在体内,特异性抑制p38α亚型对于抗炎疗效而言是必要且充分的,而进一步抑制p38β可能不会带来任何额外益处。为了辅助开发p38α选择性化合物,测定了p38β的三维结构。为此,克隆了人丝裂原活化蛋白激酶p38β的C162S以及C119S、C162S突变体,在大肠杆菌中表达并进行纯化。在存在抑制剂的情况下进行结晶试验时,最初筛选得到的结果经优化后得到了衍射分辨率达2.05 Å的晶体,从而能够确定结构(单突变体和双突变体的PDB代码分别为3gc8和3gc9)。还报道了p38α C162S突变体与同一抑制剂形成复合物的结构(PDB代码3gc7)。两种激酶结构的比较表明,它们总体上高度相似,但N端和C端结构域的相对取向存在差异,这导致p38β中ATP结合口袋的尺寸减小。可以利用这两个口袋在尺寸上的差异来实现选择性。